Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research article

CT radiomics and human-machine hybrid system for differentiating mediastinal lymphomas from thymic epithelial tumors

Authors: Han Xia, Jiahui Yu, Kehui Nie, Jun Yang, Li Zhu, Shengjian Zhang

Published in: Cancer Imaging | Issue 1/2024

Login to get access

Abstract

Background

It is difficult for radiologists, especially junior radiologists with limited experience to make differential diagnoses between mediastinal lymphomas and thymic epithelial tumors (TETs) due to the overlapping imaging features. The purpose of this study was to develop and validate a CT-based clinico-radiomics model for differentiating lymphomas from TETs and to investigate whether a human-machine hybrid system can assist junior radiologists in improving their diagnostic performance.

Methods

The patients who underwent contrast-enhanced chest CT and pathologically confirmed with lymphoma or TET at two centers from January 2011 to December 2019 and from January 2017 to December 2021 were retrospectively included and split as training/validation set and external test set, respectively. Clinical and radiomic signatures were pre-selected by elastic-net, and the models were established with the selected signatures using ensemble learning. Three radiologists independently reviewed CT images and assessed each case of the external test set with knowledge of the relevant clinical information. The diagnoses of reader 1, reader 2, and reader 3 were compared with those of the models in the external test set and further separately input to the model’s ensemble process as a human-machine system to make final decisions in the external test set. The improvement of diagnostic performance of radiologists by human-machine system was evaluated by the area under the receiver operating characteristic curve and increase rate.

Results

A total of 95 patients (51 with lymphomas and 44 with TETs) at Center 1 and 94 (52 with lymphomas and 42 with TETs) at Center 2 were enrolled and divided into training/validation sets and external test set, respectively. The diagnostic performance of the clinico-radiomics model has outperformed the junior radiologists and senior radiologist in AUC (clinico-radiomics model: 0.85 (0.76,0.92); reader 2: 0.70 (0.60,0.80); reader 3: 0.60 (0.49,0.71), reader 1: 0.76 (0.66,0.86), respectively) in the external test set. The human-machine hybrid system demonstrated significant increases in AUC (reader 1 + model: 0.87 (0.79,0.94), an increase of 14%; reader 2 + model: 0.86 (0.77,0.93), an increase of 23%; reader 3 + model: 0.84 (0.76,0.91), an increase of 40%), compared to the human performance alone.

Conclusions

The clinico-radiomics model outperformed three radiologists in differentiating lymphomas from TETs on CT. The use of the human-machine hybrid system significantly improved the performance of radiologists, especially junior radiologists. It provides a real-time decision tool to reduce bias and mistakes in radiologist diagnosis and enhances the diagnostic confidence of junior radiologists. This attempt may lead to more human-machine hybrid systems being explored in the diagnosis of different diseases to drive future clinical applications.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roden AC, Fang W, Shen Y, Carter BW, White DB, Jenkins SM, et al. Distribution of mediastinal lesions across multi-institutional, international, radiology databases. J Thorac Oncol. 2020;15:568–79.CrossRefPubMed Roden AC, Fang W, Shen Y, Carter BW, White DB, Jenkins SM, et al. Distribution of mediastinal lesions across multi-institutional, international, radiology databases. J Thorac Oncol. 2020;15:568–79.CrossRefPubMed
2.
go back to reference Ettinger DS. Wood. DE, Riely. GJ, Aisner. DL, Akerley. W, Bauman. JR. NCCN clinical practice guidelines in oncology: thymomas and thymic carcinomas. Version 1.2023. 2023. Ettinger DS. Wood. DE, Riely. GJ, Aisner. DL, Akerley. W, Bauman. JR. NCCN clinical practice guidelines in oncology: thymomas and thymic carcinomas. Version 1.2023. 2023.
3.
go back to reference P-O S. Primary mediastinal classical Hodgkin lymphoma. Adv Anat Pathol. 2016;23:285–309.CrossRef P-O S. Primary mediastinal classical Hodgkin lymphoma. Adv Anat Pathol. 2016;23:285–309.CrossRef
5.
go back to reference Kent MS, Wang T, Gangadharan SP, Whyte RI. What is the prevalence of a nontherapeutic thymectomy? Ann Thorac Surg. 2014;97:276–82. discussion 82.CrossRefPubMed Kent MS, Wang T, Gangadharan SP, Whyte RI. What is the prevalence of a nontherapeutic thymectomy? Ann Thorac Surg. 2014;97:276–82. discussion 82.CrossRefPubMed
6.
go back to reference Ackman JB, Verzosa S, Kovach AE, Louissaint A Jr., Lanuti M, Wright CD, et al. High rate of unnecessary thymectomy and its cause. Can computed tomography distinguish thymoma, lymphoma, thymic hyperplasia, and thymic cysts? Eur J Radiol. 2015;84:524–33.CrossRefPubMed Ackman JB, Verzosa S, Kovach AE, Louissaint A Jr., Lanuti M, Wright CD, et al. High rate of unnecessary thymectomy and its cause. Can computed tomography distinguish thymoma, lymphoma, thymic hyperplasia, and thymic cysts? Eur J Radiol. 2015;84:524–33.CrossRefPubMed
7.
go back to reference Hu YC, Yan WQ, Yan LF, Xiao G, Han Y, Liu CX, et al. Differentiating thymoma, thymic carcinoma and lymphoma based on collagen fibre patterns with T2- and diffusion-weighted magnetic resonance imaging. Eur Radiol. 2022;32:194–204.CrossRefPubMed Hu YC, Yan WQ, Yan LF, Xiao G, Han Y, Liu CX, et al. Differentiating thymoma, thymic carcinoma and lymphoma based on collagen fibre patterns with T2- and diffusion-weighted magnetic resonance imaging. Eur Radiol. 2022;32:194–204.CrossRefPubMed
8.
go back to reference Patterson MM, Marolf AJ. Sonographic characteristics of thymoma compared with mediastinal lymphoma. J Am Anim Hosp Assoc. 2014;50:409–13.CrossRefPubMed Patterson MM, Marolf AJ. Sonographic characteristics of thymoma compared with mediastinal lymphoma. J Am Anim Hosp Assoc. 2014;50:409–13.CrossRefPubMed
9.
go back to reference Kong J, Fu JJ, Yang W, Sun Y, Wang S, Bai J, et al. Contrast-enhanced ultrasound features of mediastinal lymphomas and thymic epithelial tumors. J Clin Ultrasound. 2020;48:19–28.CrossRefPubMed Kong J, Fu JJ, Yang W, Sun Y, Wang S, Bai J, et al. Contrast-enhanced ultrasound features of mediastinal lymphomas and thymic epithelial tumors. J Clin Ultrasound. 2020;48:19–28.CrossRefPubMed
10.
go back to reference Wang M, Kundu U, Gong Y. Pitfalls of FNA diagnosis of thymic tumors. Cancer Cytopathol. 2020;128:57–67.CrossRefPubMed Wang M, Kundu U, Gong Y. Pitfalls of FNA diagnosis of thymic tumors. Cancer Cytopathol. 2020;128:57–67.CrossRefPubMed
11.
go back to reference HUSIN TTWMZKaA. Primary mediastinal large B-cell lymphoma and its mimickers: a rare case report with literature review. Malays J Pathol. 2016;38:153–7. HUSIN TTWMZKaA. Primary mediastinal large B-cell lymphoma and its mimickers: a rare case report with literature review. Malays J Pathol. 2016;38:153–7.
12.
go back to reference Kattach H, Hasan S, Clelland C, Pillai R. Seeding of stage I thymoma into the chest wall 12 years after needle biopsy. Ann Thorac Surg. 2005;79:323–4.CrossRefPubMed Kattach H, Hasan S, Clelland C, Pillai R. Seeding of stage I thymoma into the chest wall 12 years after needle biopsy. Ann Thorac Surg. 2005;79:323–4.CrossRefPubMed
13.
go back to reference Xie YJ, Zhang SP, Liu JL, Liang XH, Zhang XL, Zhang YT, et al. Value of CT spectral imaging in the differential diagnosis of thymoma and mediastinal lymphoma. Br J Radiol. 2019;92:0598.CrossRef Xie YJ, Zhang SP, Liu JL, Liang XH, Zhang XL, Zhang YT, et al. Value of CT spectral imaging in the differential diagnosis of thymoma and mediastinal lymphoma. Br J Radiol. 2019;92:0598.CrossRef
14.
go back to reference Bakan S, Kandemirli SG, Dikici AS, Ersen E, Yildirim O, Samanci C, et al. Evaluation of anterior mediastinal solid tumors by CT perfusion: a preliminary study. Diagn Interv Radiol. 2017;23:10–4.CrossRefPubMed Bakan S, Kandemirli SG, Dikici AS, Ersen E, Yildirim O, Samanci C, et al. Evaluation of anterior mediastinal solid tumors by CT perfusion: a preliminary study. Diagn Interv Radiol. 2017;23:10–4.CrossRefPubMed
15.
go back to reference Yu CH, Zhang RP, Yang XT, Yang Z, Xin L, Zhao ZZ, et al. Dual-energy CT perfusion imaging for differentiating invasive thymomas, thymic carcinomas, and lymphomas in adults. Clin Radiol. 2022;77:e417–24.CrossRefPubMed Yu CH, Zhang RP, Yang XT, Yang Z, Xin L, Zhao ZZ, et al. Dual-energy CT perfusion imaging for differentiating invasive thymomas, thymic carcinomas, and lymphomas in adults. Clin Radiol. 2022;77:e417–24.CrossRefPubMed
16.
go back to reference Zhang W, Zhou Y, Xu XQ, Kong LY, Xu H, Yu TF, et al. A whole-tumor histogram analysis of apparent diffusion coefficient maps for differentiating thymic carcinoma from lymphoma. Korean J Radiol. 2018;19:358–65.CrossRefPubMedPubMedCentral Zhang W, Zhou Y, Xu XQ, Kong LY, Xu H, Yu TF, et al. A whole-tumor histogram analysis of apparent diffusion coefficient maps for differentiating thymic carcinoma from lymphoma. Korean J Radiol. 2018;19:358–65.CrossRefPubMedPubMedCentral
17.
go back to reference Shen J, Xue L, Zhong Y, Wu YL, Zhang W, Yu TF. Feasibility of using dynamic contrast-enhanced MRI for differentiating thymic carcinoma from thymic lymphoma based on semi-quantitative and quantitative models. Clin Radiol. 2020;75:560. e19–e25.CrossRef Shen J, Xue L, Zhong Y, Wu YL, Zhang W, Yu TF. Feasibility of using dynamic contrast-enhanced MRI for differentiating thymic carcinoma from thymic lymphoma based on semi-quantitative and quantitative models. Clin Radiol. 2020;75:560. e19–e25.CrossRef
18.
go back to reference Watanabe T, Shimomura H, Mutoh T, Saito R, Goto R, Yamada T, et al. Positron emission tomography/computed tomography as a clinical diagnostic tool for anterior mediastinal tumors. Surg Today. 2019;49:143–9.CrossRefPubMed Watanabe T, Shimomura H, Mutoh T, Saito R, Goto R, Yamada T, et al. Positron emission tomography/computed tomography as a clinical diagnostic tool for anterior mediastinal tumors. Surg Today. 2019;49:143–9.CrossRefPubMed
19.
go back to reference Byrd CT, Trope WL, Bhandari P, Konsker HB, Moradi F, Lui NS et al. Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma. J Thorac Cardiovasc Surg. 2023;165:371 – 81 e1. Byrd CT, Trope WL, Bhandari P, Konsker HB, Moradi F, Lui NS et al. Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma. J Thorac Cardiovasc Surg. 2023;165:371 – 81 e1.
20.
go back to reference Xu L, Yang X, Xiang W, Hu P, Zhang X, Li Z, et al. Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system. Front Endocrinol (Lausanne). 2023;14:1155307.CrossRefPubMed Xu L, Yang X, Xiang W, Hu P, Zhang X, Li Z, et al. Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system. Front Endocrinol (Lausanne). 2023;14:1155307.CrossRefPubMed
21.
go back to reference Saber R, Henault D, Messaoudi N, Rebolledo R, Montagnon E, Soucy G, et al. Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases. J Transl Med. 2023;21:507.CrossRefPubMedPubMedCentral Saber R, Henault D, Messaoudi N, Rebolledo R, Montagnon E, Soucy G, et al. Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases. J Transl Med. 2023;21:507.CrossRefPubMedPubMedCentral
22.
go back to reference Liu C, Zhao W, Xie J, Lin H, Hu X, Li C et al. Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer. Front Immunol. 2023;14. Liu C, Zhao W, Xie J, Lin H, Hu X, Li C et al. Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer. Front Immunol. 2023;14.
23.
go back to reference Hasserjian RP, Strobel P, Marx A. Pathology of thymic tumors. Semin Thorac Cardiovasc Surg. 2005;17:2–11.CrossRefPubMed Hasserjian RP, Strobel P, Marx A. Pathology of thymic tumors. Semin Thorac Cardiovasc Surg. 2005;17:2–11.CrossRefPubMed
24.
go back to reference Wu X, Pertovaara H, Dastidar P, Vornanen M, Paavolainen L, Marjomaki V, et al. ADC measurements in diffuse large B-cell lymphoma and follicular lymphoma: a DWI and cellularity study. Eur J Radiol. 2013;82:e158–64.CrossRefPubMed Wu X, Pertovaara H, Dastidar P, Vornanen M, Paavolainen L, Marjomaki V, et al. ADC measurements in diffuse large B-cell lymphoma and follicular lymphoma: a DWI and cellularity study. Eur J Radiol. 2013;82:e158–64.CrossRefPubMed
25.
go back to reference Kirienko M, Ninatti G, Cozzi L, Voulaz E, Gennaro N, Barajon I, et al. Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas. Radiol Med. 2020;125:951–60.CrossRefPubMed Kirienko M, Ninatti G, Cozzi L, Voulaz E, Gennaro N, Barajon I, et al. Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas. Radiol Med. 2020;125:951–60.CrossRefPubMed
26.
go back to reference He W, Xia C, Chen X, Yu J, Liu J, Pu H, et al. Computed tomography-based Radiomics for differentiation of thymic epithelial tumors and Lymphomas in Anterior Mediastinum. Front Oncol. 2022;12:869982.CrossRefPubMedPubMedCentral He W, Xia C, Chen X, Yu J, Liu J, Pu H, et al. Computed tomography-based Radiomics for differentiation of thymic epithelial tumors and Lymphomas in Anterior Mediastinum. Front Oncol. 2022;12:869982.CrossRefPubMedPubMedCentral
27.
go back to reference Zhu JJ, Shen J, Zhang W, Wang F, Yuan M, Xu H, et al. Quantitative texture analysis based on dynamic contrast enhanced MRI for differential diagnosis between primary thymic lymphoma from thymic carcinoma. Sci Rep. 2022;12:12629.CrossRefPubMedPubMedCentral Zhu JJ, Shen J, Zhang W, Wang F, Yuan M, Xu H, et al. Quantitative texture analysis based on dynamic contrast enhanced MRI for differential diagnosis between primary thymic lymphoma from thymic carcinoma. Sci Rep. 2022;12:12629.CrossRefPubMedPubMedCentral
28.
go back to reference Nioche C, Orlhac F, Boughdad S, Reuze S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for Radiomic feature calculation in Multimodality Imaging to accelerate advances in the characterization of Tumor Heterogeneity. Cancer Res. 2018;78:4786–9.CrossRefPubMed Nioche C, Orlhac F, Boughdad S, Reuze S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for Radiomic feature calculation in Multimodality Imaging to accelerate advances in the characterization of Tumor Heterogeneity. Cancer Res. 2018;78:4786–9.CrossRefPubMed
29.
go back to reference Yasaka K, Akai H, Abe O, Ohtomo K, Kiryu S. Quantitative computed tomography texture analyses for anterior mediastinal masses: differentiation between solid masses and cysts. Eur J Radiol. 2018;100:85–91.CrossRefPubMed Yasaka K, Akai H, Abe O, Ohtomo K, Kiryu S. Quantitative computed tomography texture analyses for anterior mediastinal masses: differentiation between solid masses and cysts. Eur J Radiol. 2018;100:85–91.CrossRefPubMed
30.
go back to reference Lee HS, Oh JS, Park YS, Jang SJ, Choi IS, Ryu JS. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT. Ann Nucl Med. 2016;30:309–19.CrossRefPubMed Lee HS, Oh JS, Park YS, Jang SJ, Choi IS, Ryu JS. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT. Ann Nucl Med. 2016;30:309–19.CrossRefPubMed
31.
go back to reference Yasaka K, Akai H, Nojima M, Shinozaki-Ushiku A, Fukayama M, Nakajima J, et al. Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors. Eur J Radiol. 2017;92:84–92.CrossRefPubMed Yasaka K, Akai H, Nojima M, Shinozaki-Ushiku A, Fukayama M, Nakajima J, et al. Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors. Eur J Radiol. 2017;92:84–92.CrossRefPubMed
32.
go back to reference Iannarelli A, Sacconi B, Tomei F, Anile M, Longo F, Bezzi M, et al. Analysis of CT features and quantitative texture analysis in patients with thymic tumors: correlation with grading and staging. Radiol Med. 2018;123:345–50.CrossRefPubMed Iannarelli A, Sacconi B, Tomei F, Anile M, Longo F, Bezzi M, et al. Analysis of CT features and quantitative texture analysis in patients with thymic tumors: correlation with grading and staging. Radiol Med. 2018;123:345–50.CrossRefPubMed
33.
go back to reference Nakajo MJM, Shinaji T, Nakajo M, Aoki M, Tani A, Sato M, Yoshiura T. Texture analysis of 18F-FDG peT/CT for grading thymic epithelial tumours: usefulness of combining SuV and texture parameters. Br J Radiol. 2018;91:20170546.CrossRefPubMedPubMedCentral Nakajo MJM, Shinaji T, Nakajo M, Aoki M, Tani A, Sato M, Yoshiura T. Texture analysis of 18F-FDG peT/CT for grading thymic epithelial tumours: usefulness of combining SuV and texture parameters. Br J Radiol. 2018;91:20170546.CrossRefPubMedPubMedCentral
34.
go back to reference Hu J, Zhao Y, Li M, Liu Y, Wang F, Weng Q, et al. Machine-learning-based computed tomography radiomic analysis for histologic subtype classification of thymic epithelial tumours. Eur J Radiol. 2020;126:108929.CrossRefPubMed Hu J, Zhao Y, Li M, Liu Y, Wang F, Weng Q, et al. Machine-learning-based computed tomography radiomic analysis for histologic subtype classification of thymic epithelial tumours. Eur J Radiol. 2020;126:108929.CrossRefPubMed
35.
go back to reference Xiao G, Rong WC, Hu YC, Shi ZQ, Yang Y, Ren JL, et al. MRI Radiomics Analysis for Predicting the pathologic classification and TNM staging of thymic epithelial tumors: a pilot study. AJR Am J Roentgenol. 2020;214:328–40.CrossRefPubMed Xiao G, Rong WC, Hu YC, Shi ZQ, Yang Y, Ren JL, et al. MRI Radiomics Analysis for Predicting the pathologic classification and TNM staging of thymic epithelial tumors: a pilot study. AJR Am J Roentgenol. 2020;214:328–40.CrossRefPubMed
36.
go back to reference Kayi Cangir A, Orhan K, Kahya Y, Ozakinci H, Kazak BB, Konuk Balci BM, et al. CT imaging-based machine learning model: a potential modality for predicting low-risk and high-risk groups of thymoma: impact of surgical modality choice. World J Surg Oncol. 2021;19:147.CrossRefPubMedPubMedCentral Kayi Cangir A, Orhan K, Kahya Y, Ozakinci H, Kazak BB, Konuk Balci BM, et al. CT imaging-based machine learning model: a potential modality for predicting low-risk and high-risk groups of thymoma: impact of surgical modality choice. World J Surg Oncol. 2021;19:147.CrossRefPubMedPubMedCentral
37.
go back to reference Xiao G, Hu YC, Ren JL, Qin P, Han JC, Qu XY, et al. MR imaging of thymomas: a combined radiomics nomogram to predict histologic subtypes. Eur Radiol. 2021;31:447–57.CrossRefPubMed Xiao G, Hu YC, Ren JL, Qin P, Han JC, Qu XY, et al. MR imaging of thymomas: a combined radiomics nomogram to predict histologic subtypes. Eur Radiol. 2021;31:447–57.CrossRefPubMed
38.
go back to reference Wang F-Y, Guo J, Bu G, Zhang JJ. Mutually trustworthy human-machine knowledge automation and hybrid augmented intelligence: mechanisms and applications of cognition, management, and control for complex systems. Front Inform Technol Electron Eng. 2022;23:1142–57.CrossRef Wang F-Y, Guo J, Bu G, Zhang JJ. Mutually trustworthy human-machine knowledge automation and hybrid augmented intelligence: mechanisms and applications of cognition, management, and control for complex systems. Front Inform Technol Electron Eng. 2022;23:1142–57.CrossRef
39.
go back to reference Cacciamani GE, Sanford DI, Chu TN, Kaneko M, De Castro Abreu AL, Duddalwar V, et al. Is Artif Intell Replac Our Radiol Stars? Not Yet! Eur Urol Open Sci. 2023;48:14–6. Cacciamani GE, Sanford DI, Chu TN, Kaneko M, De Castro Abreu AL, Duddalwar V, et al. Is Artif Intell Replac Our Radiol Stars? Not Yet! Eur Urol Open Sci. 2023;48:14–6.
40.
go back to reference Dov D, Assaad S, Syedibrahim A, Bell J, Huang J, Madden J, et al. A Hybrid Human-Machine Learning Approach for screening prostate biopsies can improve clinical efficiency without compromising diagnostic accuracy. Arch Pathol Lab Med. 2022;146:727–34.CrossRefPubMed Dov D, Assaad S, Syedibrahim A, Bell J, Huang J, Madden J, et al. A Hybrid Human-Machine Learning Approach for screening prostate biopsies can improve clinical efficiency without compromising diagnostic accuracy. Arch Pathol Lab Med. 2022;146:727–34.CrossRefPubMed
Metadata
Title
CT radiomics and human-machine hybrid system for differentiating mediastinal lymphomas from thymic epithelial tumors
Authors
Han Xia
Jiahui Yu
Kehui Nie
Jun Yang
Li Zhu
Shengjian Zhang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2024
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/s40644-024-00808-2
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now